
HarborSite
Research-stage platform for inserting therapeutic genes into safe genomic sites with engineered recombinases
- Soha
- Biotech
- Joylashuv
- United States
Tasdiqlangan daromad: hali ulanmagan
HarborSite sizningmi? Ushbu sahifani soʻrang va Stripe, App Store yoki Google Play’ni ulang: MRR va oʻsishingiz shu yerda toʻgʻridan-toʻgʻri manbadan koʻrinadi.
Startap haqida
HarborSite is a Harvard/Wyss Institute spinoff developing engineered recombinase enzymes to insert full-length therapeutic genes into safe sites in the genome, aiming at one-time treatments for genetic and age-related diseases. It is at research stage, with an initial focus on liver and blood cells. It is based in Boston, US, and is backed by Armenia-based SmartGate VC.
Jamoa
- Erik Aznauryan, Co-founder and CEO (Asoschi)
- George Church, Co-founder and Scientific Advisory Board Chair (Asoschi)
- Tina Lebar, Co-founder and Scientific Advisory Board Member (Asoschi)
Auditoriya
Ijtimoiy tarmoqlardagi kuzatuvchilar
Profil maʼlumotlari manbasi: Stanbase.